1. Home
  2. TERN vs MCI Comparison

TERN vs MCI Comparison

Compare TERN & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TERN
  • MCI
  • Stock Information
  • Founded
  • TERN 2017
  • MCI 1971
  • Country
  • TERN United States
  • MCI United States
  • Employees
  • TERN N/A
  • MCI N/A
  • Industry
  • TERN Biotechnology: Pharmaceutical Preparations
  • MCI Trusts Except Educational Religious and Charitable
  • Sector
  • TERN Health Care
  • MCI Finance
  • Exchange
  • TERN Nasdaq
  • MCI Nasdaq
  • Market Cap
  • TERN 499.4M
  • MCI 400.8M
  • IPO Year
  • TERN 2021
  • MCI N/A
  • Fundamental
  • Price
  • TERN $6.80
  • MCI $19.98
  • Analyst Decision
  • TERN Buy
  • MCI
  • Analyst Count
  • TERN 5
  • MCI 0
  • Target Price
  • TERN $18.30
  • MCI N/A
  • AVG Volume (30 Days)
  • TERN 1.8M
  • MCI 40.4K
  • Earning Date
  • TERN 11-12-2024
  • MCI 01-01-0001
  • Dividend Yield
  • TERN N/A
  • MCI 8.46%
  • EPS Growth
  • TERN N/A
  • MCI N/A
  • EPS
  • TERN N/A
  • MCI 1.82
  • Revenue
  • TERN N/A
  • MCI N/A
  • Revenue This Year
  • TERN N/A
  • MCI N/A
  • Revenue Next Year
  • TERN N/A
  • MCI N/A
  • P/E Ratio
  • TERN N/A
  • MCI $9.88
  • Revenue Growth
  • TERN N/A
  • MCI N/A
  • 52 Week Low
  • TERN $4.32
  • MCI $12.96
  • 52 Week High
  • TERN $11.40
  • MCI $19.24
  • Technical
  • Relative Strength Index (RSI)
  • TERN 52.65
  • MCI 53.91
  • Support Level
  • TERN $6.41
  • MCI $19.72
  • Resistance Level
  • TERN $7.14
  • MCI $20.29
  • Average True Range (ATR)
  • TERN 0.48
  • MCI 0.37
  • MACD
  • TERN 0.10
  • MCI 0.02
  • Stochastic Oscillator
  • TERN 59.76
  • MCI 35.23

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. These investments are typically made to small or middle market companies. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

Share on Social Networks: